We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.69%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$15.2B
AUM Growth
+$1.14B
Cap. Flow
+$754M
Cap. Flow %
4.96%
Top 10 Hldgs %
15.87%
Holding
1,269
New
352
Increased
317
Reduced
269
Closed
320

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$124M
2
TXN icon
Texas Instruments
TXN
+$113M
3
UNH icon
UnitedHealth
UNH
+$106M
4
PM icon
Philip Morris
PM
+$106M
5
TJX icon
TJX Companies
TJX
+$93.3M

Sector Composition

Rank Sector Weight
1 Healthcare 19.99%
2 Consumer Discretionary 12.3%
3 Technology 11.57%
4 Communication Services 10.98%
5 Financials 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRC
326
DELISTED
MRC Global
MRC
$10.3M 0.07%
+508,894
New +$9.27M
TEAM icon
327
Atlassian
TEAM
$22B
$10.3M 0.07%
425,805
+382,419
+881% +$10.3M
SQM icon
328
Sociedad Química y Minera de Chile
SQM
$19.6B
$10.2M 0.07%
+356,517
New +$10.1M
NKTR icon
329
Nektar Therapeutics
NKTR
$2.39B
$10.2M 0.07%
55,332
+15,452
+39% +$3.14M
ALV icon
330
Autoliv
ALV
$8.6B
$10.2M 0.07%
124,747
+92,337
+285% +$6.86M
FICO icon
331
Fair Isaac
FICO
$28.7B
$10.1M 0.07%
85,031
+79,927
+1,566% +$9.5M
LII icon
332
Lennox International
LII
$18.8B
$10.1M 0.07%
+65,679
New +$10M
PRGO icon
333
Perrigo
PRGO
$1.4B
$10.1M 0.07%
120,811
+107,270
+792% +$9.3M
RES icon
334
RPC Inc
RES
$1.24B
$10.1M 0.07%
507,506
-32,399
-6% -$607K
NKE icon
335
Nike
NKE
$61.9B
$10M 0.07%
197,600
+180,106
+1,030% +$9.24M
MSM icon
336
MSC Industrial Direct
MSM
$7.02B
$9.98M 0.07%
+108,069
New +$8.91M
DAL icon
337
Delta Air Lines
DAL
$55.9B
$9.98M 0.07%
202,795
-415,361
-67% -$18.9M
LLY icon
338
Eli Lilly
LLY
$1.07T
$9.96M 0.07%
+135,359
New +$10.1M
GLOG
339
DELISTED
GASLOG LTD
GLOG
$9.95M 0.07%
618,252
-222,538
-26% -$3.54M
INGR icon
340
Ingredion
INGR
$6.38B
$9.95M 0.07%
+79,622
New +$10.1M
OXY icon
341
Occidental Petroleum
OXY
$57B
$9.92M 0.07%
+139,249
New +$9.89M
LBRDK icon
342
Liberty Broadband Class C
LBRDK
$4.15B
$9.91M 0.07%
133,770
+27,420
+26% +$1.93M
GWR
343
DELISTED
Genesee & Wyoming Inc.
GWR
$9.86M 0.06%
+142,076
New +$10.1M
AON icon
344
Aon
AON
$77.3B
$9.85M 0.06%
+88,327
New +$9.84M
REGN icon
345
Regeneron Pharmaceuticals
REGN
$68.8B
$9.82M 0.06%
26,755
+17,116
+178% +$6.51M
MDCO
346
DELISTED
Medicines Co
MDCO
$9.63M 0.06%
+283,622
New +$10.1M
CSC
347
DELISTED
Computer Sciences
CSC
$9.61M 0.06%
161,743
+154,845
+2,245% +$8.95M
LVLT
348
DELISTED
Level 3 Communications Inc
LVLT
$9.54M 0.06%
169,362
-1,104,177
-87% -$58.3M
DHI icon
349
D.R. Horton
DHI
$41B
$9.48M 0.06%
346,836
+296,953
+595% +$8.48M
COO icon
350
Cooper Companies
COO
$13.7B
$9.47M 0.06%
216,628
+116,088
+115% +$5.07M

Similar funds

Marshall Wace's Q4 2016 Portfolio in Review

As of Q4 2016, Marshall Wace held 1,269 positions worth $15.2B, up 8.1% from $14.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $754M of net new capital in Q4 2016, opening 352 new positions and adding to 317 existing holdings. Its largest new stake was Texas Instruments: 1,581,130 shares worth $115M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Zoetis, an estimated $221M trimmed.

  • Marshall Wace's largest Q4 2016 buy was Texas Instruments: 1,581,130 shares worth $115M.
  • Marshall Wace added most to Amazon in Q4 2016, an estimated $124M increase.
  • Marshall Wace's biggest Q4 2016 reduction was Zoetis, cutting an estimated $221M.
  • Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q4 2016, selling an estimated $240M.
  • Marshall Wace's ten largest holdings make up 16% of its $15.2B portfolio in Q4 2016.
  • Marshall Wace opened 352 new positions and closed 320 in Q4 2016.
  • Marshall Wace's portfolio value rose 8.1% quarter-over-quarter to $15.2B.

Based on Marshall Wace's 13F filing for Q4 2016, filed 10 Feb 2017.